--- title: "Central Garden & Pet | 8-K: FY2026 Q3 Revenue Misses Estimate at USD 882.36 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295011502.md" datetime: "2026-08-05T20:36:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295011502.md) - [en](https://longbridge.com/en/news/295011502.md) - [zh-HK](https://longbridge.com/zh-HK/news/295011502.md) generator: "portal-rs" --- # Central Garden & Pet | 8-K: FY2026 Q3 Revenue Misses Estimate at USD 882.36 M Revenue: As of FY2026 Q3, the actual value is USD 882.36 M, missing the estimate of USD 892.38 M. EPS: As of FY2026 Q3, the actual value is USD 1.45, missing the estimate of USD 1.547. EBIT: As of FY2026 Q3, the actual value is USD 133.61 M. ### Fiscal 2026 Third Quarter Financial Results (Compared to Q3 FY 2025) #### Consolidated Performance - Net sales decreased by 8% to $882 million from $961 million. - Organic net sales increased by 2% to $862 million from $842 million. - Gross profit was $317 million, a decrease of 5% from $332 million, with gross margin expanding by 130 basis points to 35.9% from 34.6%. - Selling, general and administrative (SG&A) expenses decreased by 3% to $191 million from $197 million. - Non-GAAP SG&A decreased by 6% to $182 million from $193 million. - Operating income decreased by 7% to $126 million from $135 million, with operating margin expanding by 20 basis points to 14.3% from 14.1%. - Non-GAAP operating income decreased by 2% to $136 million from $139 million, with non-GAAP operating margin expanding by 90 basis points to 15.4% from 14.5%. - Other income was $2 million, slightly above the prior year. - Net interest expense was $8 million, lower than a year ago. - Net income decreased by 5% to $90 million from $95 million. - Non-GAAP net income decreased by 2% to $96 million from $98 million. - Adjusted EBITDA was $162 million, a decrease of $5 million from $167 million, with margin expanding by 100 basis points to 18.3% from 17.3%. #### Pet Segment - Net sales decreased by 19% to $400 million from $493 million, reflecting the exit of the pet distribution business. - Organic net sales increased by 2% to $380 million. - Operating income decreased by 12% to $67 million from $76 million, with margin expanding by 120 basis points to 16.7% from 15.5%. - Non-GAAP operating income decreased by 2% to $76 million from $78 million, with non-GAAP operating margin expanding by 320 basis points to 19.0% from 15.8%. - Adjusted EBITDA decreased by $2 million to $86 million from $88 million, with margin expanding by 350 basis points to 21.4% from 17.9%. #### Garden Segment - Net sales increased by 3% to $482 million from $468 million, primarily driven by Wild Bird, Fertilizer and Controls, and Grass Seeds. - Operating income increased by 9% to $90 million from $83 million, with margin expanding by 100 basis points to 18.7% from 17.7%. - Non-GAAP operating income increased by 7% to $91 million from $85 million, with non-GAAP operating margin expanding by 70 basis points to 18.9% from 18.2%. - Adjusted EBITDA increased by $5 million to $101 million from $96 million, with margin expanding by 50 basis points to 20.9% from 20.4%. ### Liquidity and Debt (Compared to Q3 FY 2025) - Cash provided by operations was $327 million, compared with $265 million. - Cash and cash equivalents at June 27, 2026, totaled $997 million, compared with $713 million. - Total debt was $1.2 billion, consistent with the prior year period. - Gross leverage ended the third quarter at 2.8x, compared with 2.9x in the prior year. - Net leverage was 0.5x. - As of June 27, 2026, $128 million remained available for future stock repurchases. ### Strategic Initiatives - Following the quarter, Central Garden & Pet Company entered into a definitive agreement to acquire an 80% interest in TRIXIE Heimtierbedarf GmbH & Co. KG, a leading European pet supplies and pet snacks company, for up to €400 million including earn-out payments. - The transaction is expected to close in the first half of fiscal 2027. ### Fiscal 2026 Guidance Central Garden & Pet Company raised its outlook for fiscal 2026 non-GAAP diluted EPS from $2.70 or better to $2.85 or better. This revised outlook is driven by continued margin discipline, ongoing investment in growth initiatives, and portfolio optimization. Capital expenditures for fiscal 2026 are projected to be approximately $50 million, focused on maintenance, productivity initiatives, and targeted growth investments. ### Related Stocks - [CENT.US](https://longbridge.com/en/quote/CENT.US.md) ## Related News & Research - [CENT: Record cash flow, margin gains, and the TRIXIE deal set the stage for sustained growth and M&A](https://longbridge.com/en/news/298608131.md) - [Ashley Tisdale Teams Up with Nylabone to Celebrate a New Kind of Chew Toy | CENT Stock News](https://longbridge.com/en/news/299902330.md) - [‘Open Your Eyes,’ Says Top Investor About Oracle Stock](https://longbridge.com/en/news/301160283.md) - [Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.](https://longbridge.com/en/news/301114413.md) - [Palantir vs. Oracle – Why Daniel Ives Says Buy One, Hold the Other](https://longbridge.com/en/news/301155464.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**